£595.00

It has never been this cheap. We have no record of a lower price.

£595 today · cheaper than every other day in the last 3 months

The 2016-2021 Outlook for Bladder Cancer Therapeutics in Japan

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 32 days · 32 data points (no recent data)

Historical
Generating forecast…
£595.00 £565.25 £577.15 £589.05 £600.95 £612.85 £624.75 28 July 2026 04 August 2026 12 August 2026 20 August 2026 28 August 2026
View at Amazon ↗

Price data last checked 59 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 32 days • 1 price levels

Days at Price
32 days 0 8 16 24 32 £595 Days at Price

Price Analysis

Most common price: £595 (32 days, 100.0%)

Price range: £595 - £595

Price levels: 1 different prices over 32 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
22 September 2015
Listed Since
16 November 2016

Similar Products You Might Like

The 2025-2030 World Outlook for Bladder Cancer Therapeutics
98% match

The 2025-2030 World Outlook for Bladder Cancer Therapeutics

Price unavailable
The 2025-2030 World Outlook for Transitional Cell Bladder Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Transitional Cell Bladder Cancer Therapeutics

Price unavailable
The 2023-2028 Outlook for Overactive Bladder Treatments in India
97% match

The 2023-2028 Outlook for Overactive Bladder Treatments in India

£515.00 25 Aug 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India
97% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in India

£515.00 20 Aug 2026
The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan
97% match

The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan

£595.00 23 Sep 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States
97% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in the United States

£520.00 21 Aug 2026
The 2023-2028 Outlook for Overactive Bladder Treatments in the United States
97% match

The 2023-2028 Outlook for Overactive Bladder Treatments in the United States

£520.00 28 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care in the United States

£520.00 22 Aug 2026
Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care
97% match

Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care

Elsevier

£119.36 24 Sep 2026
The 2016-2021 Outlook for Urological Catheters in the United States
97% match

The 2016-2021 Outlook for Urological Catheters in the United States

£595.00 28 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
The 2026-2031 World Outlook for Overactive Bladder Therapeutics
97% match

The 2026-2031 World Outlook for Overactive Bladder Therapeutics

£885.00 19 Sep 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 21 Aug 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 21 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 01 Oct 2026
The 2021-2026 World Outlook for Cancer Biomarkers
97% match

The 2021-2026 World Outlook for Cancer Biomarkers

£795.00 21 Aug 2026
The 2023-2028 Outlook for Cancer Screenings in the United States
97% match

The 2023-2028 Outlook for Cancer Screenings in the United States

£520.00 20 Aug 2026
The 2016-2021 Outlook for Cancer Therapies in Asia
97% match

The 2016-2021 Outlook for Cancer Therapies in Asia

£425.00 22 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening in India
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in India

£515.00 01 Oct 2026
The 2016-2021 Outlook for Cancer Therapies in North America & the Caribbean
97% match

The 2016-2021 Outlook for Cancer Therapies in North America & the Caribbean

£425.00 22 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan
97% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan

£495.00 25 Aug 2026
The 2016-2021 Outlook for Liver Cancer Drugs in Japan
96% match

The 2016-2021 Outlook for Liver Cancer Drugs in Japan

£595.00 27 Aug 2026